These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25894874)

  • 1. Neuroimaging in Parkinson's disease: a future perspective.
    Brooks DJ
    Neurodegener Dis Manag; 2015; 5(2):105-8. PubMed ID: 25894874
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies over the staging of alpha-synuclein pathology in Parkinson's disease.
    Kalaitzakis ME; Graeber MB; Gentleman SM; Pearce RK
    Acta Neuropathol; 2008 Jul; 116(1):125-8; author reply 129-31. PubMed ID: 18446352
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroimaging: current role in detecting pre-motor Parkinson's disease.
    Godau J; Hussl A; Lolekha P; Stoessl AJ; Seppi K
    Mov Disord; 2012 Apr; 27(5):634-43. PubMed ID: 22508281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein in Parkinson's disease: pathogenic function and translation into animal models.
    Eschbach J; Danzer KM
    Neurodegener Dis; 2014; 14(1):1-17. PubMed ID: 24080741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
    Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral alpha-synuclein and Parkinson's disease.
    Olanow CW; Wakeman DR; Kordower JH
    Mov Disord; 2014 Jul; 29(8):963-6. PubMed ID: 25043799
    [No Abstract]   [Full Text] [Related]  

  • 8. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
    Li B; Zhang Y; Yuan Y; Chen N
    Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological roles of α-synuclein in neurological disorders.
    Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
    Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.
    Kontopoulos E; Parvin JD; Feany MB
    Hum Mol Genet; 2006 Oct; 15(20):3012-23. PubMed ID: 16959795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein immunohistochemistry in two cases of co-occurring idiopathic Parkinson's disease and motor neuron disease.
    Klos KJ; Josephs KA; Parisi JE; Dickson DW
    Mov Disord; 2005 Nov; 20(11):1515-20. PubMed ID: 16035099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson's disease.
    Zhou J; Broe M; Huang Y; Anderson JP; Gai WP; Milward EA; Porritt M; Howells D; Hughes AJ; Wang X; Halliday GM
    Acta Neuropathol; 2011 Jun; 121(6):695-704. PubMed ID: 21400129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and neuroimaging features of patient with early-onset Parkinson's disease with dementia carrying SNCA p.G51D mutation.
    Tokutake T; Ishikawa A; Yoshimura N; Miyashita A; Kuwano R; Nishizawa M; Ikeuchi T
    Parkinsonism Relat Disord; 2014 Feb; 20(2):262-4. PubMed ID: 24315198
    [No Abstract]   [Full Text] [Related]  

  • 15. From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease.
    Bellucci A; Zaltieri M; Navarria L; Grigoletto J; Missale C; Spano P
    Brain Res; 2012 Oct; 1476():183-202. PubMed ID: 22560500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo gastric detection of α-synuclein inclusions in Parkinson's disease.
    Sánchez-Ferro Á; Rábano A; Catalán MJ; Rodríguez-Valcárcel FC; Fernández Díez S; Herreros-Rodríguez J; García-Cobos E; Álvarez-Santullano MM; López-Manzanares L; Mosqueira AJ; Vela Desojo L; López-Lozano JJ; López-Valdés E; Sánchez-Sánchez R; Molina-Arjona JA
    Mov Disord; 2015 Apr; 30(4):517-24. PubMed ID: 25113060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?
    Halliday G; McCann H; Shepherd C
    Expert Rev Neurother; 2012 Jun; 12(6):673-86. PubMed ID: 22650170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-synuclein imaging: a critical need for Parkinson's disease research.
    Eberling JL; Dave KD; Frasier MA
    J Parkinsons Dis; 2013; 3(4):565-7. PubMed ID: 24192754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Parkinson's disease start in the gut?
    Gershanik OS
    Arq Neuropsiquiatr; 2018 Feb; 76(2):67-70. PubMed ID: 29489958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seeing Is Believing: Alpha-Synuclein Oligomers in Parkinson's Disease Brain.
    Williams-Gray C
    Mov Disord; 2015 Sep; 30(10):1324. PubMed ID: 26227159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.